Main menu

Translational and clinical research applications of long-read sequencing technologies in oncology

Translational and clinical research applications of long-read sequencing technologies in oncology
resources.return_to_resources
  • shared.published_on: February 25 2026

In this talk from AGBT 2026, Marilyn Li presents clinical research from Children's Hospital of Philadelphia (CHOP) on rapid multiomic tumour classification, demonstrating how Oxford Nanopore sequencing enables ultra-rapid methylation classification and comprehensive genomic profiling in a single consolidated assay.

Register below to receive your on demand viewing link.

resources.download

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag